Osteopenia Completed Phase 4 Trials for Pamidronic acid (DB00282)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00108394Osteopenia and Renal Osteodystrophy: Evaluation and ManagementTreatment